Metamizole Kalceks

Metamizole, the active ingredient in Metamizole Kalceks, is a pyrazolone derivative presented as an injectable solution for intramuscular and intravenous use. It is employed to relieve acute pain, postoperative pain, fever and colic in adult patients. It is indicated for short‑term management of severe pain and high fever where other analgesics are insufficient.

GNH USA supplies Metamizole Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assurance processes and regulatory approvals across EU and other markets.

Metamizole is a non‑opioid analgesic used for conditions involving acute pain and fever.

- Acute pain: provides rapid relief of severe, short‑term pain. - Post‑operative pain: reduces discomfort after surgical procedures. - Fever: lowers elevated body temperature. - Colic: alleviates abdominal cramping associated with colic.

Metamizole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypotension: transient drop in blood pressure after injection. - Nausea: mild gastrointestinal upset. - Dizziness: sensation of light‑headedness. - Injection site pain: local discomfort at the administration site.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells, potentially life‑threatening. - Severe allergic reactions: including anaphylaxis and skin rash. - Stevens‑Johnson syndrome: rare but serious skin and mucous membrane disorder.

Before using Metamizole, consider the following safety measures.

- Renal function: assess baseline kidney status. - Blood counts: monitor complete blood count regularly. - Hypersensitivity: avoid in patients with known allergy to pyrazolones. - Cardiovascular disease: use cautiously in patients with unstable heart conditions. - Hepatic impairment: adjust use if liver function is compromised. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metamizole can interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Anticoagulants: increased risk of bleeding. - Other NSAIDs: heightened gastrointestinal and renal toxicity. - Allopurinol: elevated risk of agranulocytosis.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate potassium loss. - Antihypertensives: potential reduction in blood pressure control. - Lithium: increased lithium serum concentrations.